Evidence map›Paper›PMID 31831639›Full record

ArticleScience (New York, N.Y.)2019

Depletion of microbiome-derived molecules in the host using

Chun-Jun Guo, Breanna M Allen, Kamir J Hiam, Dylan Dodd, Will Van Treuren, Steven Higginbottom, Kazuki Nagashima, Curt R Fischer, Justin L Sonnenburg, Matthew H Spitzer and 1 more

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 100 papers.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 171 citations in OpenAlex.

  1. Review
  2. Article
  3. Gut microbes · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Research square · 2026
    Article
  9. bioRxiv : the preprint server for biology · 2026
    Article
  10. pH regulates gut bacterial tryptophan metabolism.NPJ biofilms and microbiomes · 2026
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Detection ofVirulence · 2025
    Article
  18. Article
  19. Article
  20. Review

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Chun-Jun GuoDepartment of Bioengineering and ChEM-H, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0002-7227-4591
Breanna M AllenGraduate Program in Biomedical Sciences, Departments of Otolaryngology and Microbiology and Immunology, Helen Diller Family Comprehensive Cancer Center, Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0002-4830-6792
Kamir J HiamGraduate Program in Biomedical Sciences, Departments of Otolaryngology and Microbiology and Immunology, Helen Diller Family Comprehensive Cancer Center, Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0002-1956-0257
Dylan DoddDepartment of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Will Van TreurenDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Steven HigginbottomDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.ORCID 0000-0002-4609-6840
Kazuki NagashimaDepartment of Bioengineering and ChEM-H, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0002-8593-136X
Curt R FischerDepartment of Bioengineering and ChEM-H, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0003-3386-9813
Justin L SonnenburgDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.ORCID 0000-0003-2299-6817
Matthew H SpitzerGraduate Program in Biomedical Sciences, Departments of Otolaryngology and Microbiology and Immunology, Helen Diller Family Comprehensive Cancer Center, Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA 94143, USA. fischbach@fischbachgroup.org matthew.spitzer@ucsf.edu.ORCID 0000-0002-5291-3819
Michael A FischbachDepartment of Bioengineering and ChEM-H, Stanford University, Stanford, CA 94305, USA. fischbach@fischbachgroup.org matthew.spitzer@ucsf.edu.ORCID 0000-0003-3079-8247
Chan Zuckerberg Initiative (United States) · USParker Institute for Cancer Immunotherapy · USStanford University · USCornell University · US

Funding

Dietary and Microbial Reprogramming of Intestinal Microbiota-Produced MetabolitesR01DK101674 · NIDDK · STANFORD UNIVERSITY · PI FISCHBACH, MICHAEL ANDREW, MEYER, TIMOTHY W · 2014 to 2024
$6.5M
Impact of Diet on Intestinal Microbiota-Host DynamicsR01DK085025 · NIDDK · STANFORD UNIVERSITY · PI JUSTIN L SONNENBURG · 2010 to 2026
$6.4M
PREDOCTORAL TRAINING IN BIOMEDICAL SCIENCEST32GM008568 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANSEL, KARL MARK · 1995 to 2019
$6.3M
A complete map of the top 100 molecules from the gut microbiomeDP1DK113598 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FISCHBACH, MICHAEL ANDREW · 2016 to 2020
$5.5M
An integrative and generalizable approach to modulate microbiota small molecules in the hostDP2HD101401 · NICHD · WEILL MEDICAL COLL OF CORNELL UNIV · PI GUO, CHUN-JUN · 2019 to 2019
$2.5M
Quantitatively modeling immune responses to cancerDP5OD023056 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SPITZER, MATTHEW · 2016 to 2020
$1.9M
Identification and characterization of natural products from the human microbiotaR01DK110174 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FISCHBACH, MICHAEL ANDREW · 2016 to 2019
$1.4M
UCSF DVS CyTOF Mass CytometerS10OD018040 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LANIER, LEWIS LEE · 2014 to 2014
$600k
Modulation of gut bacteria-derived host metabolitesK08DK110335 · NIDDK · STANFORD UNIVERSITY · PI DODD, DYLAN · 2018 to 2021
$573k
NICHD NIH HHS DP2 HD101401NIDDK NIH HHS DP1 DK113598NIDDK NIH HHS K08 DK110335NIDDK NIH HHS R01 DK085025NIDDK NIH HHS R01 DK101674NIDDK NIH HHS R01 DK110174NIGMS NIH HHS T32 GM008568NIH HHS DP5 OD023056NIH HHS S10 OD018040
6 · The paper itself

Abstract

The gut microbiota produce hundreds of molecules that are present at high concentrations in the host circulation. Unraveling the contribution of each molecule to host biology remains difficult. We developed a system for constructing clean deletions in

Indexed as

Host Microbial InteractionsAnimalsClostridiumCRISPR-Associated Protein 9CRISPR-Cas SystemsGastrointestinal MicrobiomeGene DeletionGene EditingMetabolic Networks and PathwaysMiceMice, Inbred StrainsCRISPR-Associated Protein 9

Identifiers

PMID31831639
PMCPMC7141153
OpenAlexW2994701067

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.